- Home
- NMRA vs UHG Comparison
NMRA vs UHG Comparison
Compare NMRA & UHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMRA
- UHG
- Stock Information
- Founded
- NMRA 2019
- UHG 2004
- Country
- NMRA United States
- UHG United States
- Employees
- NMRA N/A
- UHG N/A
- Industry
- NMRA
- UHG Homebuilding
- Sector
- NMRA
- UHG Consumer Discretionary
- Exchange
- NMRA Nasdaq
- UHG Nasdaq
- Market Cap
- NMRA 234.5M
- UHG 242.0M
- IPO Year
- NMRA 2023
- UHG N/A
- Fundamental
- Price
- NMRA $2.08
- UHG $3.75
- Analyst Decision
- NMRA Buy
- UHG
- Analyst Count
- NMRA 8
- UHG 0
- Target Price
- NMRA $7.14
- UHG N/A
- AVG Volume (30 Days)
- NMRA 2.2M
- UHG 245.0K
- Earning Date
- NMRA 08-06-2025
- UHG 08-07-2025
- Dividend Yield
- NMRA N/A
- UHG N/A
- EPS Growth
- NMRA N/A
- UHG N/A
- EPS
- NMRA N/A
- UHG 0.76
- Revenue
- NMRA N/A
- UHG $449,877,017.00
- Revenue This Year
- NMRA N/A
- UHG N/A
- Revenue Next Year
- NMRA N/A
- UHG N/A
- P/E Ratio
- NMRA N/A
- UHG $5.58
- Revenue Growth
- NMRA N/A
- UHG 5.24
- 52 Week Low
- NMRA $0.61
- UHG $1.60
- 52 Week High
- NMRA $17.19
- UHG $6.93
- Technical
- Relative Strength Index (RSI)
- NMRA 70.06
- UHG 52.87
- Support Level
- NMRA $1.70
- UHG $3.83
- Resistance Level
- NMRA $2.85
- UHG $4.22
- Average True Range (ATR)
- NMRA 0.32
- UHG 0.38
- MACD
- NMRA 0.05
- UHG 0.03
- Stochastic Oscillator
- NMRA 58.08
- UHG 54.27
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.
About UHG United Homes Group Inc
United Homes Group Inc operates as a homebuilder which operates with a land-light idea in the Southeast. The company currently has a presence in South Carolina, North Carolina, and Georgia and focuses on providing high-quality, affordable homes for the entry-level and first-move-up segments. The company has three reportable segments: GSH South Carolina, Rosewood, and Other.